Cardiology Organizations Bracing For Major Revenue Drop Because of COVID-19
Information comes from a survey MedAxiom, an American College of Cardiology company, conveyed.
MedAxiom, an American College of Cardiology company, surveyed its members from March 24-28 to assess the effect of the COVID-19 outbreak on cardiovascular organizations. Representatives of 89 organizations responded. The majority (77.5%) have 11 or more cardiologists.
Here are some of the results:
• Between 50% and 75% of the respondents expected to see their organization’s second-quarter revenues drop by almost in half (47.3%). Between 25% and 50% of the respondents expected to see second-quarter revenues fall by a little over a third (37.8%).
• Between 25% and 50% of the respondents had put 29.9% of their staff on paid leave and 10.7% on unpaid leave.
• Over 20% of respondents have closed or are planning to close 50% or more of their clinics.
• Most programs are seeing a reschedule rate of between 50% to 75% in cardiovascular procedures. Between 25% and 50% have rescheduled close to half (42.5%) of their imaging studies.
• Nearly 70% of cardiovascular programs are utilizing advanced practice providers for telehealth services.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More
